Mild/moderate long-term musculoskeletal conditions affecting back, lower limbs or physical activity levels Musculoskeletal Diseases
Conditions
Interventions
Participants are randomised to Group 1 or 2.
Group 1: two physiotherapy sessions. Session 1: participants are asked about their activity levels and advised how they might become more
Sponsors
Oxford University Hospitals NHS Trust (UK)
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1. Patients referred for physiotherapy assessment and advice by GPs for any mild/moderate/none severe musculoskeletal conditions effecting physical activity (e.g., chronic back pain, fibromyalgia, lower limb arthritis) with pain (rated 4 or above on a visual analogue scale) lasting at least 3 months, and considered physically able to undertake the programme 2. Participants self-reporting < 120 mins (4 x 30 min) of moderate intensity exercise a week 3. Participants able to perform 6-minute timed walk test (own pace, no walking aid) with non-severe reports of pain (equal or less than 6/10 on the VAS scale) during screening 4. Participant is willing and able to give informed consent for participation in the study. Patient is fluent in English and able to read screens 5. Male or female, aged 18 years or above
Exclusion criteria
Exclusion criteria: 1. Participants scoring an average pain VAS > 6 on walk test 2. Participants unable/unwilling to provide consent 3. Participants with a recent history of an illness likely to interfere with the ability to undertake the programme safely: serious cardiac or respiratory diagnoses, lower limb fractures (last 12 months), blindness, systemic illness, those reporting that a doctor had told them not to exercise 4. Pregnancy 5. Unable to participate in the intervention
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 6-minute timed walk test. Timepoints for all outcomes: baseline, 3 months (post-intervention) and 6 months. | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. 7-day mean step count using an Omron HJ-720ITC pedometer 2. Blood pressure 3. Peak flow 4. The British Heart Foundation's Daily Activities Questionnaire will be used to measure the amount of physical activity people have engaged in during the previous 7 days 5. Visual analogue scales will measure pain intensity, average pain and fatigue 6. The Positive and Negative Affect Schedule (PANAS) self-report measure will be used to measure positive and negative affect 7. A single question about happiness will be used from the SF-36 (short-form health survey) 8. Self-efficacy will be measured by the Generalised Self-Efficacy scale 9. A self-report exercise diary will be used to provide information about adherence to the intervention 10. Quality of life will be assessed using the EQ-5D-5L and a global health rating question will be included 11. EQ-5D-5L and resource use diaries will be used to provide data regarding health economics 12. Participants will be asked to report adverse events, including falls Timepoints for all outcomes: baseline, 3 months (post-intervention) and 6 months. | — |
Countries
United Kingdom
Outcome results
None listed